| RS1322090113 |
CACNA2D2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1322092837 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1322095182 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1322095633 |
MSH6
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1322100078 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1322140250 |
ACAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1322141600 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Asphyxiating thoracic dystrophy 3 |
| RS1322144248 |
MRPS22
|
Health Risk |
Pathogenic |
Hypotonia with lactic acidemia and hyperammonemia, Hypotonia with lactic acidemia and hyperammonemia |
| RS1322162359 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1322172446 |
SCN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brugada syndrome 5 |
| RS1322189326 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS1322189782 |
CFAP410
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy with or without macular staphyloma, Retinal dystrophy with or without macular staphyloma |
| RS13222 |
AKR1C2
|
Health Risk |
Pathogenic |
46, XY disorder of sex development due to testicular 17 |
| RS1322206611 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1322207888 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1322231013 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1322244059 |
FXR1
|
Health Risk |
Pathogenic |
Myopathy, congenital proximal |
| RS1322248626 |
SMARCAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1322260893 |
OCA2
|
Health Risk |
Pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS1322266202 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS1322278463 |
PRPH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Patterned dystrophy of the retinal pigment epithelium, PRPH2-related disorder |
| RS1322282571 |
SRP19
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Severe congenital neutropenia |
| RS1322313531 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1322313985 |
MAN2B1
|
Health Risk |
Pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS1322319973 |
BAP1
|
Health Risk |
Pathogenic |
— |
| RS1322344930 |
OBSCN
|
Health Risk |
risk factor |
Rhabdomyolysis, susceptibility to |
| RS1322345200 |
SERPING1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary angioedema type 1, Hereditary angioedema type 1 |
| RS1322369710 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS13223704 |
GHRHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated growth hormone deficiency type IB, Isolated growth hormone deficiency type IB |
| RS1322406234 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1322423998 |
MYO15A
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1322454680 |
CEL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1322458975 |
CACNA1S
|
Health Risk |
Pathogenic |
Congenital myopathy 18, Hypokalemic periodic paralysis |
| RS1322472709 |
HK1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with visual defects and brain anomalies, Neurodevelopmental disorder with visual defects and brain anomalies |
| RS1322496244 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS1322503729 |
IGF1R
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Growth delay due to insulin-like growth factor I resistance |
| RS1322527075 |
ZNF750
|
Health Risk |
Pathogenic |
Seborrhea-like dermatitis with psoriasiform elements, Seborrhea-like dermatitis with psoriasiform elements |
| RS1322527832 |
PHKB
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1322541651 |
PEX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 6A (Zellweger), Peroxisome biogenesis disorder |
| RS1322543333 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1322549762 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1322560606 |
CYP11B1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1322566644 |
DNAAF4
|
Health Risk |
Pathogenic |
— |
| RS1322586198 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 1 |
| RS1322586390 |
ZNF423
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 14, Nephronophthisis 14 |
| RS1322587342 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1322590833 |
COL6A1
|
Health Risk |
Pathogenic |
— |
| RS1322596650 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1322620894 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1322622893 |
SPG11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hereditary spastic paraplegia 11 |
| RS1322629595 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrochondrogenesis 2, Otospondylomegaepiphyseal dysplasia |
| RS1322638469 |
IRF6
|
Health Risk |
Pathogenic |
Orofacial cleft 6, susceptibility to |
| RS1322650779 |
HMGCL
|
Health Risk |
Likely pathogenic |
Deficiency of hydroxymethylglutaryl-CoA lyase, Deficiency of hydroxymethylglutaryl-CoA lyase |
| RS1322658068 |
MTO1
|
Health Risk |
Pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS1322662992 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1322689394 |
ALDOB
|
Health Risk |
Likely pathogenic |
— |
| RS1322698222 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1322705042 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 14 |
| RS1322708706 |
COL9A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1322721879 |
CEP78
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1322754256 |
NR1H4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1322783114 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS1322791959 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1322795745 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS1322796318 |
ITPR1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 29, Spinocerebellar ataxia type 29 |
| RS1322799946 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease type 1A |
| RS1322800124 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS1322803235 |
ADGRA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1322807658 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS1322819699 |
LNPK
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum |
| RS1322829123 |
COL9A1
|
Health Risk |
Likely pathogenic |
— |
| RS1322831151 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS1322832121 |
SPEG
|
Health Risk |
Pathogenic |
— |
| RS1322871046 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1322871899 |
DYNC2H1
|
Health Risk |
Pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS1322884865 |
DYNC2H1
|
Health Risk |
Pathogenic/Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS1322889530 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1322900367 |
TET2
|
Health Risk |
Pathogenic |
EBV-positive nodal T- and NK-cell lymphoma, EBV-positive nodal T- and NK-cell lymphoma |
| RS1322905273 |
ADAR
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 6, Symmetrical dyschromatosis of extremities |
| RS1322913410 |
TARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 21, Combined oxidative phosphorylation defect type 21 |
| RS1322947350 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 |
| RS1322951938 |
INVS
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Infantile nephronophthisis |
| RS1322974029 |
FARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS1322979131 |
TGM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Lamellar ichthyosis |
| RS1322986343 |
XPC
|
Health Risk |
Pathogenic |
— |
| RS1322986962 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1322987070 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1322987429 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
CFTR-related disorder, Cystic fibrosis |
| RS1323001046 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1323016653 |
FDXR
|
Health Risk |
Pathogenic/Likely pathogenic |
Auditory neuropathy-optic atrophy syndrome, Multiple mitochondrial dysfunctions syndrome 9b |
| RS1323035335 |
SEC63
|
Health Risk |
Likely pathogenic |
Polycystic liver disease 2, Polycystic liver disease 2 |
| RS1323060528 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1323074715 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Cardiovascular phenotype |
| RS1323078491 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1323094107 |
MINPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pontocerebellar hypoplasia, type 16 |
| RS1323094309 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1323097421 |
MYBPC3
|
Health Risk |
Pathogenic |
— |
| RS1323138654 |
TULP1
|
Health Risk |
Likely pathogenic |
— |
| RS1323139544 |
PUS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Myopathy, lactic acidosis |
| RS1323140691 |
MAST1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |